The Food and Drug Administration released a safety alert regarding a higher risk for blood clots in women taking birth control pills containing Drospirenone, such as Yaz and Yazmin.
As a result of the alert, Bayer must revise Yaz and Yasmin labels to include the new FDA warning. The new labels must report that some epidemiologic studies reported as high as a three-fold increase in the risk of blood clots for drospirenone-containing products when compared to products containing levonorgestrel or some other progestins, whereas other epidemiological studies found no additional risk of blood clots with drospirenone-containing products, according to the FDA. The labels will also include a summary of the previously released results of an FDA-funded study of the blood clot risk.
The FDA recommends that women talk to their healthcare provider about their risk for blood clots before choosing a birth control method.
Yaz Side Effects
While Yaz is often effective in preventing pregnancy and treating symptoms of PMDD, the side effects associated with the drug can be severe and sometimes life threatening. They include:
- Heart Attack
- Pulmonary embolism
- Blood Clots
- Deep Vein Thrombosis
- Gallbladder Disease
- Sudden death
- See other Yaz side effects
Contact a Yaz Attorney
If you or a loved one has experienced adverse side effects from the use of Yaz, you may qualify for compensation to help with the cost of your medical expenses, as well as your pain and suffering. To contact a Yaz lawyer for a free consultation and Yaz lawsuit information, call Matthews and Associates toll free at (888) 923-7001.FacebookTwitter
by Matthews & Associates